What is Ginkgo Bioworks's cumulative cost basis?

Ginkgo Bioworks (DNA) reported cumulative cost basis of $211.74M in Q1 2026.

How has Ginkgo Bioworks's cumulative cost basis changed year-over-year?

Ginkgo Bioworks's cumulative cost basis decreased by 41.4% year-over-year, from $361.25M to $211.74M.

What is the long-term trend for Ginkgo Bioworks's cumulative cost basis?

Over 5 years (2020 to 2025), Ginkgo Bioworks's cumulative cost basis has grown at a 8.8% compound annual growth rate (CAGR), from $155.21M to $236.64M.

Ginkgo Bioworks DNA Cumulative Cost Basis

Cumulative Cost Basis at other companies

Bio-Rad LaboratoriesBIO

——

Emergent BiosolutionsEBS

——

GeneDx HoldingsWGS

——

Twist Bioscience CorporationTWST

——

Guardant HealthGH

——

Other financials

Income statement

See full

Revenue$19.5M-49.1%

Gross profit$16.4M-52.0%

Operating income-$71.4M+11.9%

Net income-$82.6M+9.2%

EPS (diluted)-$1.42+27.6%

Balance sheet

See full

Cash & equivalents$188.7M-46.9%

Total debt$410.7M-5.5%

Total equity$443.2M-31.6%

Total assets$1.0B-20.1%

Cash flow

See full

Operating cash flow-$46.7M+9.4%

CapEx$1.9M-74.6%

Free cash flow-$48.6M+17.8%

Valuation

See full

Market cap$625.16M+24.6%

Enterprise value$847.19M+45.9%

P/S4.4×+2.2×

Profitability

See full

Operating margin-210.7%+7.6pp

Net margin-215.4%+8.3pp

FCF margin-119%-21.2pp

Returns & leverage

See full

Return on equity-55.8%-1.8pp

Debt / equity0.9×+0.3×

Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ginkgo Bioworks's cumulative cost basis?: Ginkgo Bioworks (DNA) reported cumulative cost basis of $211.74M in Q1 2026.
How has Ginkgo Bioworks's cumulative cost basis changed year-over-year?: Ginkgo Bioworks's cumulative cost basis decreased by 41.4% year-over-year, from $361.25M to $211.74M.
What is the long-term trend for Ginkgo Bioworks's cumulative cost basis?: Over 5 years (2020 to 2025), Ginkgo Bioworks's cumulative cost basis has grown at a 8.8% compound annual growth rate (CAGR), from $155.21M to $236.64M.